Inventor · disambiguated record
Gabriel Lopez-Berestein
Also filed as: LOPEZ-BERESTEIN GABRIEL
42 granted patents·11 pending applications·1,512 citations·filing 1984–2021
98Inventor score
Top patents by PatentIndex Score
53 records- 0197US5417978ALiposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and useUNIV TEXAS·Filed 1993·Granted May 23, 1995·339 cites·10 claims
- 0294US5178876AHydrophobic cis-platinum complexes efficiently incorporated into liposomesUNIV TEXAS·Filed 1991·Granted Jan 12, 1993·69 cites·9 claims
- 0393US7923548B2Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1UNIV TEXAS·Filed 2007·Granted Apr 12, 2011·9 cites·24 claims
- 0492US7754872B2Liposomal phosphodiester, phophorothioate, and p-ethoxy oligonucleotidesUNIV TEXAS·Filed 2007·Granted Jul 13, 2010·11 cites·9 claims
- 0591US8734853B2HDL particles for delivery of nucleic acidsSOOD ANIL K·Filed 2009·Granted May 27, 2014·142 cites·25 claims
- 0690US4812312ALiposome-incorporated nystatinUNIV TEXAS·Filed 1987·Granted Mar 14, 1989·68 cites·13 claims
- 0790US4663167AComposition and method for treatment of disseminated fungal infections in mammalsUNIV TEXAS·Filed 1984·Granted May 5, 1987·56 cites·6 claims
- 0888US5811119AFormulation and use of carotenoids in treatment of cancerUNIV TEXAS·Filed 1996·Granted Sep 22, 1998·83 cites·2 claims
- 0987US8338366B2Bioactive FUS1 peptides and nanoparticle-polypeptide complexesLIN JACKI·Filed 2006·Granted Dec 25, 2012·13 cites·31 claims
- 1087US8067390B2Therapeutic targeting of interleukins using siRNA in neutral liposomesMERRITT WILLIAM M·Filed 2008·Granted Nov 29, 2011·19 cites·20 claims
- 1187US5855911ALiposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotidesUNIV TEXAS·Filed 1995·Granted Jan 5, 1999·65 cites·19 claims
- 1285US8895717B2Delivery of siRNA by neutral lipid compositionsSOOD ANIL K·Filed 2006·Granted Nov 25, 2014·23 cites·12 claims
- 1385US7220853B2Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1UNIV TEXAS·Filed 2002·Granted May 22, 2007·13 cites·5 claims
- 1485US7176302B2Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotidesUNIV TEXAS·Filed 2003·Granted Feb 13, 2007·12 cites·6 claims
- 1585US5186940AHydrophobic cis-platinum complexes efficiently incorporated into liposomesUNIV TEXAS·Filed 1991·Granted Feb 16, 1993·23 cites·18 claims
- 1684US7285288B1Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotidesUNIV TEXAS·Filed 1997·Granted Oct 23, 2007·124 cites·46 claims
- 1779US7704962B1Small oligonucleotides with anti-tumor activityUNIV TEXAS·Filed 2000·Granted Apr 27, 2010·11 cites·17 claims
- 1878US6107457ABcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growthUNIV TEXAS·Filed 1995·Granted Aug 22, 2000·36 cites·21 claims
- 1974US6042846ALiposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotidesUNIV TEXAS·Filed 1998·Granted Mar 28, 2000·22 cites·19 claims
- 2074US5117022AHydrophobic cis-platinum complexes efficiently incorporated into liposomesUNIV TEXAS·Filed 1988·Granted May 26, 1992·42 cites·28 claims
- 2173US8859727B2Bioactive FUS1 peptides and nanoparticle-polypeptide complexesUNIV TEXAS·Filed 2012·Granted Oct 14, 2014·2 cites·18 claims
- 2272US4863739ALiposome compositions of anthracycline derivativesUNIV TEXAS·Filed 1987·Granted Sep 5, 1989·24 cites·22 claims
- 2371US6977244B2Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotidesUNIV TEXAS·Filed 1996·Granted Dec 20, 2005·29 cites·43 claims
- 2471US5968737AMethod of identifying inhibitors of glutathione S-transferase (GST) gene expressionUNIV MISSISSIPPI·Filed 1996·Granted Oct 19, 1999·58 cites·11 claims
- 2570US5178875ALiposomal-polyene preliposomal powder and method for its preparationUNIV TEXAS·Filed 1991·Granted Jan 12, 1993·33 cites·68 claims
- 2667US8299040B2Methods for treating cancer targeting transglutaminaseMEHTA KAPIL·Filed 2007·Granted Oct 30, 2012·3 cites·6 claims
- 2767US4950432APolyene microlide pre-liposomal powdersUNIV TEXAS·Filed 1987·Granted Aug 21, 1990·34 cites·18 claims
- 2863US5032404ALipsome-incorporation of polyenesUNIV TEXAS·Filed 1989·Granted Jul 16, 1991·26 cites·19 claims
- 2962US5213970AMethod for obtaining soluble antitumor factorUNIV TEXAS·Filed 1987·Granted May 25, 1993·33 cites·10 claims
- 3058US6200597B1Formulation and use of carotenoids in treatment of cancerUNIV TEXAS·Filed 1998·Granted Mar 13, 2001·17 cites·6 claims
- 3157US7309692B1Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1UNIV TEXAS·Filed 1996·Granted Dec 18, 2007·10 cites·11 claims
- 3257US4978654AComposition and method for treatment of disseminated fungal infections in mammalsUNIV TEXAS·Filed 1987·Granted Dec 18, 1990·22 cites·11 claims
- 3356US12077760B2DNA aptamers and use thereof for the treatment of cancerUNIV TEXAS·Filed 2019·Granted Sep 3, 2024·0 cites·14 claims
- 3455US2003219474A1Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotidesFiled 2003·Application pending·0 cites
- 3553US2005008664A1Compositions and methods related to lipid:emodin formulationsUNIV TEXAS·Filed 2003·Application pending·0 cites
- 3653US2011064664A1Methods and compositions involving chitosan nanoparticlesUNIV TEXAS·Filed 2008·Application pending·0 cites
- 3752US5965158ALiposomal-polyene preliposomal powder and method for its preparationUNIV TEXAS·Filed 1997·Granted Oct 12, 1999·8 cites·3 claims
- 3852US5041581AHydrophobic cis-platinum complexes efficiently incorporated into liposomesUNIV TEXAS·Filed 1986·Granted Aug 20, 1991·12 cites·40 claims
- 3950US9073851B2Compositions and methods for treating cancerUNIV TEXAS·Filed 2012·Granted Jul 7, 2015·0 cites·27 claims
- 4049US2012070486A1Methods and compositions related to prefoldin and its regulationSOOD ANIL K·Filed 2008·Application pending·0 cites
- 4149US2004022772A1Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growthFiled 2003·Application pending·0 cites
- 4248US2023167453A1Rna aptamers and use thereof for treating cancerUNIV TEXAS·Filed 2021·Application pending·0 cites
- 4346US2003129222A1Liposomal imexonFiled 2001·Application pending·0 cites
- 4445US6537804B1BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome stimulated cell growthUNIV TEXAS·Filed 1996·Granted Mar 25, 2003·3 cites·22 claims
- 4544US4981690ALiposome-incorporated mepartricinUNIV TEXAS·Filed 1987·Granted Jan 1, 1991·9 cites·12 claims
- 4644US2004043950A1WT1 antisense oligos for the inhibition of breast cancerUNIV TEXAS·Filed 2003·Application pending·0 cites
- 4744US2016375050A1Methods and compositions involving chitosan nanoparticlesUNIV TEXAS·Filed 2016·Application pending·0 cites
- 4840US2015306077A1Novel Compositions and Methods for Treating CancerUNIV TEXAS·Filed 2015·Application pending·0 cites
- 4939US10874622B2Dual assembly nanoparticlesUNIV TEXAS·Filed 2016·Granted Dec 29, 2020·0 cites·4 claims
- 5038US2002143062A1Method to incorporate N-(4-hydroxyphenyl) retinamide in liposomesUNIV TEXAS·Filed 2001·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gabriel Lopez-Berestein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →